Gilead Sciences signs exclusive agreement with CVS for hepatitis C drug

January 7, 2015 2:26 AM

4 0

Gilead Sciences signs exclusive agreement with CVS for hepatitis C drug

On Monday Gilead Sciences won exclusive access to CVS Health Corp. customers, against its rival AbbVie in a growing marketing war over costly hepatitis C drugs.

According to the benefits manager, Gilead's Harvoni and Sovaldi will be the only medicines covered in CVS Health main list of drugs and also in its list for health plans through the Affordable Care Act, Medicare Part D and Medicaid.

Also read: MOVES-StormHarbour launches loan franchise with Paul Martin hire

Read more

To category page

Loading...